Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Гиперчувствительный пневмонит

Список литературы

  1. Raghu G., Remy-Jardin M., Ryerson Ch. J. et al. Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2020; V. 202, Iss. 3: pp e36–e69.
  2. Selman M., Pardo A., King T.E. Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am. J. Respir. Crit. Care Med. 2012;186: 314–324
  3. Camarena A., Juarez A., Mejıa M. et al. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder’s disease. Am. J. Respir. Crit. Care Med. 2001;163:1528–1533.
  4. Camarena A., Aquino-Galvez A., Falfan-Valencia R. et al. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder’s hypersensitivity pneumonitis. Respir. Med. 2010;104:889–894.
  5. Aquino-Galvez A., Camarena A., Montaño M. et al. Transporter associated with antigen processing (TAP) 1 gene polymorphisms in patients with hypersensitivity pneumonitis. Exp. Mol. Pathol. 2008;84:173–177.
  6. Hill M.R., Briggs L., Montaño M.M. et al. Promoter variants in tissue inhibitor of metalloproteinase-3 (TIMP-3) protect against susceptibility in pigeon breeders’ disease. Thorax 2004;59:586–590.
  7. Jinta T., Miyazaki Y., Kishi M. et al. The pathogenesis of chronic HP in common with IPF. Am. J. Clin. Pathol. 2010;134:613–620
  8. Fernandez Perez E.R., Kong A.M., Raimundo K. et al. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Ann. Am. Thorac. Soc. 2018;15:460 -469
  9. Hanak V., Golbin J.M., Ryu J.H. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin. Proc. 2007;82:812–816
  10. Yoshida K, Suga M, Nishiura Y, Arima K, Yoneda R, Tamura M, et al. . Occupational hypersensitivity pneumonitis in Japan: data on a nationwide epidemiological study. Occup Environ Med. (1995) 52:570–4. 10.1136/oem.52.9.570
  11. Dalphin JC. Extrinsic allergic alveolitis in agricultural environment. Rev Prat. (1992) 42:1790–6.
  12. Morell F, Villar A, Ojanguren I, Muñoz X, Cruz MJ, Sansano I, et al. . Hypersensitivity pneumonitis and (Idiopathic) pulmonary fibrosis due to feather duvets and pillows. Arch Bronconeumol. (2021) 57:87–93. 10.1016/j.arbres.2019.12.003
  13. Vasakova M., Morell F., Walsh S. et al. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am. J. Respir. Crit. Care Med. 2017;196:680–689.
  14. Flaherty K.R. Wells A.U., Cottin V. et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N. Engl. J. Med. 2019;381(18):1718-1727. doi: 10.1056/NEJMoa1908681.
  15. Авдеев С.Н., Чикина С.Ю., Тюрин И.Е., Белевский А.С., Терпигорев С,А., Ананьев а Л.П., Визель А.А., Болдина М.В., Демко И.В., Лещенко И.В., Трофименко И.Н., К иняйкин М.Ф., Степанян И.Э., Зайцева А.С., Петров Д.В. Хронические фиброзирующие интерстициальные заболевания легких с прогрессирующим фиброзным фенотипом: резолюция Междисциплинарного Совета экспертов . Пульмонология. 2021. Т.31. № 4. C. 505-510.
  16. Reich J.M. Chirping rales in bird-fancier’s lung. Chest 1993;104:326–327.
  17. Lacasse Y., Selman M., Costabel U. et al. HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med 2003;168:952–958.
  18. Черняк, Б. А. Гиперчувствительный пневмонит: от этиологии и патогенеза к диагностике и лечению / Б. А. Черняк, И. И. Воржева, И. Н. Трофименко // Фарматека. – 2021. – Т. 28. – № 5. – С. 17-31. – DOI 10.18565/pharmateca.2021.5.17- 31.
  19. Kumar R., Spalgais S., Ranga V. Hypersensitivity pneumonitis: clinical, radiological and pathological profile of 103 patients from North India. Monaldi Arch. Chest Dis. 2020;90(3). doi: 10.4081/monaldi.2020.1307.
  20. Sakamoto S., Furukawa M., Shimizu H. et al. Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis. Respir. Med. 2020;174:106196. doi: 10.1016/j.rmed.2020.106196.
  21. Onishi Y., Kawamura T., Higashino T. et al. Clinical features of chronic summer-type hypersensitivity pneumonitis and proposition of diagnostic criteria. Respir. Investig. 2020 Jan;58(1):59-67. doi: 10.1016/j.resinv.2019.09.003.
  22. Fernandez Perez E.R., Swigris J.J., Forssen A.V. et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest 2013;144:1644–1651.
  23. Johannson K.A., Elicker B.M., Vittinghoff E. et al. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax 2016;71(10):951-4. doi: 10.1136/thoraxjnl-2016- 208286.
  24. Авдеев, С. Н. Гиперчувствительный пневмонит / С. Н. Авдеев // Пульмонология. – 2021. – Т. 31. – № 1. – С. 88-99. – DOI 10.18093/0869-0189-2021-31-1-88-99.
  25. Гиперчувствительный пневмонит / И. В. Демко, Н. В. Гордеева, А. Ю. Крапошина [и др.] // Бюллетень физиологии и патологии дыхания. – 2015. – № 58. – С. 109-114.
  26. Lacasse Y., Girard M., Cormier Y. Recent advances in hypersensitivity pneumonitis. Chest. 2012;142(1):208-217. doi: 10.1378/chest.11-2479.
  27. Pereira C.A.C., Soares M.R., Boaventura R. et al. Squawks in interstitial lung disease prevalence and causes in a cohort of one thousand patients. Medicine (Baltimore) 2019; 98: e16419. doi: 10.1097/MD.0000000000016419.
  28. Rodrigo M.J., Benavent M.I., Cruz M.J. et al. Detection of specific antibodies to pigeon serum and bloom antigens by enzyme linked immunosorbent assay in pigeon breeder’s disease. Occup. Environ. Med. 2000; 57: 159–164. doi: 10.1136/oem.57.3.159.
  29. Perez-Padilla R., Salas J., Chapela R. et al. Mortality in Mexican patients with chronic pigeon breeder’s lung compared with those with usual interstitial pneumonia. Am. Rev. Respir. Dis. 1993; 148: 49–53.
  30. Ohtsuka Y., Munakata M., Tanimura K. et al. Smoking promotes insidious and chronic farmer’s lung disease, and deteriorates the clinical outcome. Intern. Med. 1995; 34: 966– 971.
  31. De Sadeleer L.J., Hermans F., De Dycker E. et al. Effects of corticosteroid treatment and antigen avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study. J. Clin. Med. 2018; 8 (1). 14. doi: 10.3390/jcm8010014.
  32. Sema M, Miyazaki Y, Tsutsui T, Tomita M, Eishi Y, Inase N. Environmental levels of avian antigen are relevant to the progression of chronic hypersensitivity pneumonitis during antigen avoidance. Immun. Inflamm. Dis. 2018; 6 (1): 154-162. doi: 10.1002/iid3.202.
  33. Tsutsui T, Miyazaki Y, Kuramochi J, Uchida K, Eishi Y, Inase N. The amount of avian antigen in household dust predicts the prognosis of chronic bird-related hypersensitivity pneumonitis. Ann. Am. Thorac. Soc. 2015;12 (7): 1013-1021. doi: 10.1513/AnnalsATS.201412-569OC.
  34. Fernández Pérez E.R., Koelsch T.L., Leone P.M. et al. Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management. Semin. Respir. Crit. Care Med. 2020; 41 (2): 214-228. doi: 10.1055/s-0040-1701250.
  35. Nishimura K., Izumi T., Kitaichi M. et al. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases. Chest. 1993; 104 (4): 1149- 1155. doi: 10.1378/chest.104.4.1149.
  36. Ahmed Sh., Khanduri S., Husain M. et al. Diagnostic Accuracy of Multidetector CT in Detection of Early Interstitial Lung Disease With Its Role in Characterization. Cureus. 2020; 12 (5): e8253. doi: 10.7759/cureus.8253.
  37. Shobeirian F., Mehrian P., Doroudinia A. Hypersensitivity Pneumonitis High-resolution Computed Tomography Findings, and Their Correlation with the Etiology and the Disease Duration. Prague Med. Rep. 2020; 121 (3): 133-141. doi: 10.14712/23362936.2020.12.
  38. Salisbury M., Gu T., Murray S. et al. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory Chest 2019;155(4):699-711. doi: 10.1016/j.chest.2018.08.1076.
  39. Hirschmann JV, Pipavath SN, Godwin JD. Hypersensitivity pneumonitis: a historical, clinical, and radiologic review. Radiographics. 2009;29 (7): 1921-38
  40. Glazer CS, Rose CS, Lynch DA. Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging. 2002;17 (4): 261-72
  41. Клинико-рентгено-морфологическая диагностика гиперчувствительного пневмонита / А. Л. Черняев, Э. В. Кусраева, М. В. Самсонова [и др.] // Бюллетень сибирской медицины. – 2021. – Т. 20. – № 4. – С. 93-102. – DOI 10.20538/1682-0363- 2021-4-93-102.
  42. Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, et al. Pathologic findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest 2017;152:502–509.
  43. Castonquay M, Ryu J, Yi E, Tazelaar H. Granulomas and giant cells in hypersensitivity pneumonitis. Hum Pathol 2015;46:607–613.
  44. Chiba S, Tsuchiya K, Akashi T, Ishizuka M, Okamoto T, Furusawa H, et al. Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia-like pattern: correlation between histopathologic and clinical findings. Chest 2016;149:1473–1481.
  45. Kitaichi M, Shimizu S, Tamaya M, Takaki M, Inoue Y. Pathology of hypersensitivity pneumonitis. In: Sharma OP, editor. Clinical focus series, hypersensitivity pneumonitis. New Delhi, India: Jaypee Brothers Medical Publishers; 2013. pp. 22–32.
  46. Raghu G., Remy-Jardin M., Myers J.L. et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2018; 198 (5): e44-e68.
  47. Akashi T, Takemura T, Ando N, Eishi Y, Kitagawa M, Takizawa T, et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am J Clin Pathol. 2009;131:405–415
  48. Ohtani Y, Saiki S, Kitaichi M, Usui Y, Inase N, Costabel U, Yoshizawa Y Chronic bird fancier’s lung: histopathological and clinical correlation: an application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005, 60(8):665–671. 10.1136/thx.2004.027326 [PubMed: 16061708]
  49. Reynolds H.Y. Present status of bronchoalveolar lavage in interstitial lung disease. Curr. Opin. Pulm. Med. 2009;15:479-85.
  50. Cordeiro C.R., Jines J.C., Alfaro T., Ferreira A.J. Bronchoalveolar lavage in occupational lung diseases. Semin. Respir. Crit. Care Med. 2007;28:504-13.
  51. Ohshimo S., Bonella F., Cui A., et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 1043-7.
  52. Morell F., Villar A., Montero M.A. et al. Chronic hypersensitivity pneumnitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir. Med. 2013; 1: 685–694.
  53. Welker L., Jorres R.A., Costabel U., Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur. Respir. J. 2004;24(6):1000- 1006.
  54. Adams T.N., Newton C.A., Batra K., et al. Utility of bronchoalveolar lavage and transbronchial biopsy in patients with hypersensitivity pneumonitis. Lung. 2018;196(5):617-622.
  55. Tzilas V., Tzouvelekis A., Bouros E. et al. Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern. Eur. Respir. J. 2019;54(5).
  56. Santos V, Martins N, Sousa C, Jacob M, Padrao E, Melo N, et al. Hypersensitivity pneumonitis: main features characterization in a Portuguese cohort. Pulmonology 2019 10 29 [Epub]. PMID: 10.1016/j.pulmoe.2019.09.004.
  57. Kebbe J, Abdo T. Interstitial lung diseae: the diagnostic role of bronchoscopy. J Thorac Dis. 2017 Sep;9(Suppl 10):S996-S1010. doi: 10.21037/jtd.2017.06.39. PMID: 29214060; PMCID: PMC5696547.
  58. Pajares V., Puzo C., Castillo D. et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 2014;19:900–906.
  59. Sheth J.S., Belperio J.A., Fishbein M.C. et al. Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease. Chest 2017;151:389–399.
  60. Sindhwani G., Shirazi N., Sodhi R., Raghuvanshi S., Rawat J. Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without ‘idiopathic pulmonary fibrosis pattern’ on HRCT scan: Experience from a tertiary care center of North India. Lung India 2015;32:453–456.
  61. Lacasse Y., Fraser R.S., Fournier M., Cormier Y. Diagnostic accuracy of transbronchial biopsy in acute farmer’s lung disease. Chest 1997; 112:1459–1465.
  62. Chami H.A., Diaz-Mendoza J., Chua A. et al. Transbronchial Biopsy and Cryobiopsy in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease. Ann. Am. Thorac. Soc. 2021;18(1):148-161. doi: 10.1513/AnnalsATS.202005- 421OC.
  63. Ayed A.K., Raghunathan R. Thoracoscopy versus open lung biopsy in the diagnosis of ILD: a randomised controlled trial. J. Roy Coll. Surg. Edinb, 2000;45:159–163.
  64. Miller J.D., Urschel J.D., Cox G. et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac. Surg. 2000;70:1647–1650.
  65. Blewett C.J., Bennett W.F., Miller J.D., Urschel J.D. Open lung biopsy as an outpatient procedure. Ann Thorac Surg 2001;71:1113–1115.
  66. Ayed A.K. Video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse interstitial lung disease: a prospective study. J. Cardiovasc. Surg. (Torino) 2003;44:115– 118.
  67. Yamaguchi M., Yoshino I., Suemitsu R. et al. Elective video-assisted thoracoscopic lung biopsy for interstitial lung disease. Asian Cardiovasc. Thorac. Ann. 2004;12:65–68.
  68. Lettieri C.J., Veerappan G.R., Helman D.L., Mulligan C.R., Shorr A.F. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 2005;127:1600–1605.
  69. Coutinho G.F., Pancas R., Magalhães E. et al. Diagnostic value of surgical lung biopsy: comparison with clinical and radiological diagnosis. Eur. J. Cardiothorac. Surg. 2008;33:781–785.
  70. Guerra M., Miranda J.A., Leal F., Vouga L. Interstitial lung disease: diagnostic accuracy and safety of surgical lung biopsy. Rev. Port. Pneumol. 2009;15:433–442.
  71. Fibla J.J., Molins L., Blanco A. et al. Video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: a prospective, multi-center study in 224 patients. Arch. Bronconeumol. 2012;48:81–85.
  72. Rotolo N., Imperatori A., Dominioni L. et al. Efficacy and safety of surgical lung biopsy for interstitial disease: experience of 161 consecutive patients from a single institution in Italy. Sarcoidosis Vasc Diffuse Lung Dis 2015;32: 251–258.
  73. Samejima J., Tajiri M., Ogura T. et al. Thoracoscopic lung biopsy in 285 patients with diffuse pulmonary disease. Asian Cardiovasc. Thorac. Ann. 2015;23:191–197.
  74. Lettieri C.J., Veerappan G.R., Helman D.L., Mulligan C.R., Shorr A.F. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 2005;127:1600–1605.
  75. Park J.H., Kim D.K., Kim D.S. et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. Eur. J. Cardiothorac. Surg. 2007;31:1115– 1119.
  76. Kreider M.E., Hansen-Flaschen J., Ahmad N.N. et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann. Thorac. Surg. 2007;83:1140–1144.
  77. Hanzawa S., Tateishi T., Takemura T. et al. The Analysis of Surgical Lung Biopsy and Explanted Lung Specimens Sheds Light on the Pathological Progression of Chronic Bird- related Hypersensitivity Pneumonitis. Intern. Med. 2019;58(8):1145-1150. doi: 10.2169/internalmedicine.1142-18.
  78. Wright J.L., Churg A., Hague C.J. et al. Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. Mod. Pathol. 2020; 33(4):616-625. doi: 10.1038/s41379-019-0389-3.
  79. Tibana R.C.C., Soares M.R., Storrer K.M. et al. Clinical diagnosis of patients subjected to surgical lung biopsy with a probable usual interstitial pneumonia pattern on high- resolution computed tomography. BMC Pulm. Med. 2020;20(1):299. doi: 10.1186/s12890-020-01339-9.
  80. Mooney J.J., Koth L.L. Surgical lung biopsy over bronchoalveolar lavage in chronic hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2014;189(3):371-2. doi: 10.1164/rccm.201309-1736LE.
  81. Xu J.F., Shen L., Zhang Y. et al. Lung biopsy-proved hypersensitivity pneumonitis without known offending antigen: characteristics and follow-up. Clin. Respir. J. 2014 Jul;8(3):297-304. doi: 10.1111/crj.12071.
  82. Fernández Pérez E.R., Travis W.D., Lynch D.A., Brown K.K., ; Johannson K.A., Selman M., Ryu J.H., Wells A.U., Huang Y-C.T., Pereira C.A.C., Scholand M-B., Villar A., Inase N., Evans R.B., Mette S., Frazer-Green L.. Executive Summary Diagnosis and Evaluation of Hypersensitivity Pneumonitis CHEST Guideline and Expert Panel Report. CHEST, May 2021, p 1-20

  1. Nowicka U., Wiatr E., Radzikowska E. et al. Pulmonary Function Abnormalities in Regard to Age at the Time of Diagnosis of Hypersensitivity Pneumonitis. Adv Exp Med Biol. 2015;861:75-84. doi: 10.1007/5584_2015_137.
  2. Gimenez A., Storrer K., Kuranishi L. et al. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018 Apr;73(4):391-392. doi: 10.1136/thoraxjnl-2017-210035.
  3. Tafuro F., Corradi M.. An approach to interpreting restrictive spirometric pattern results in occupational settings. Med. Lav. 2016 Dec 13;107(6):419-436.
  4. Ejima M., Okamoto T., Suzuki T. et al. Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis. BMC Pulm Med. 2021;21(1):243. doi: 10.1186/s12890-021-01608-1.
  5. Ziora D., Jastrzebski D., Lubina M et al. High-resolution computed tomography in hypersensitivity pneumonitis - correlation with pulmonary function. Ann. Agric. Environ. Med. 2005;12(1):31-4.
  6. Schmidt C.D., Jensen R.L., Christensen L.T. et al. Longitudinal pulmonary function changes in pigeon breeders. Chest. 1988;93(2):359-63. doi: 10.1378/chest.93.2.359.
  7. Ojanguren I., Morell F., Ramón M.A., et al. Long-term outcomes in chronic hypersensitivity pneumonitis. Allergy. 2019;74(5):944-952. doi: 10.1111/all.13692.
  8. Guerrero Zúñiga S., Sánchez Hernández J., Mateos Toledo H. et al. Small airway dysfunction in chronic hypersensitivity pneumonitis. Respirology. 2017;22(8):1637- 1642. doi: 10.1111/resp.13124.
  9. Walsh S.L., Sverzellati N., Devaraj A. et al. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur. Radiol. 2012;22(8):1672-9. doi: 10.1007/s00330-012-2427-0.
  10. Wells A.U., Flaherty K.R., Brown K.K. et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir. Med. 2020;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9.
  11. Dias O.M., Baldi B.G., Ferreira J.G. et al. Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis. ERJ Open Res. 2018;4(3):00043-2018. doi: 10.1183/23120541.00043-2018.
  12. Dowman L., Hill C.J., Holland A.E. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;(10): CD006322. doi: 10.1002/14651858.CD006322.pub3.
  13. Tonelli R., Cocconcelli E., Lanini B. et al, Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study. Clini EM. BMC Pulm Med. 2017;17(1):130. doi: 10.1186/s12890-017-0476-5.
  14. Holland A.E., Hill C.J., Conron M., et al Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549-54. doi: 10.1136/thx.2007.088070.
  15. Alhamad E.H., Cal J.G. Predictors of mortality in interstitial lung disease patients without pulmonary hypertension. Ann. Thorac. Med. 2020; 15 (4): 238-243. doi: 10.4103/atm.ATM_438_20.
  16. Lama V.N., Flaherty K.R., Toews G.B. et al. Prognostic value of desaturation during a 6- minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003;168:1084 - 1090.

  1. Walters G.I., Mokhlis J.M., Moore V.C. et al. Characteristics of hypersensitivity pneumonitis diagnosed by interstitial and occupational lung disease multi-disciplinary team consensus. Respir. Med. 2019;155:19–25.
  2. Ohtani Y., Inase N., Miyake S. et al. Fatal outcome in chronic bird fancier's lung. Am. J. Med. 2002; 112(7): 588-590.
  3. de Gracia J., Morell F., Bofill J.M. et al. Time of exposure as a prognostic factor in avian hypersensitivity pneumonitis. Respir. Med. 1989; 83(2): 139-143.
  4. Kawamoto Y., Oda S., Tanaka M. Antigen avoidance in people with hypersensitivity pneumonitis: A scoping review. Heart Lung. 2021;50(3):407-416. doi: 10.1016/j.hrtlng.2021.01.023.
  5. Quirce S., Vandenplas O., Campo P. et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71(6):765-79. doi: 10.1111/all.12866.
  6. Spagnolo P., Rossi G., Cavazza A. et al. Hypersensitivity Pneumonitis: A Comprehensive Review. J Investig Allergol Clin Immunol 2015;25 (4): 237-250.
  7. Cormier Y, Bélanger J. Long-term physiologic outcome after acute farmer's lung. Chest. 1985;87:796-800.
  8. Kokkarinen J.I., Tukiainen H.O., Terho E.O. Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung. Am Rev Respir Dis. 1992; 145(1), 3-5.
  9. Shiroshita A., Tanaka Yu, Nakashima K. et al. Diagnostic accuracy of specific IgG antibodies for bird fancier’s lung: a systematic review and meta-analysis. Ann. Transl. Med. 2019; 7(22): 655. doi: 10.21037/atm.2019.10.65.
  10. Орлова Г.П. Особенности лечебной тактики при профессиональных интерстициальных заболеваниях легких. Медицина труда и промышленная экология. – 2017. - № 9. - стр. 144.
  11. Adegunsoye A., Oldham J.M., Fernández Pérez E.R. et al. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. ERJ Open Res. 2017; 3: 00016-2017 doi.org/10.1183/23120541.00016-2017.
  12. Alberti ML, Rincon-Alvarez E, Buendia-Roldan I, Selman M. Hypersensitivity Pneumonitis: Diagnostic and Therapeutic Challenges. Front Med (Lausanne). 2021;8:718299. Published 2021 Sep 23. doi:10.3389/fmed.2021.718299
  13. Fiddler Ch.A., Simler N., Thillai M., Parfrey H. Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single- centre experience. Clin. Respir. J. 2019;13(12):791-794. doi: 10.1111/crj.13086.
  14. Tzilas V., Tzouvelekis A., Bouros E. et al. Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study. ERJ Open Res. 2020;6(4):00152-2020. doi: 10.1183/23120541.00152-2020.
  15. Schaeffer M.R., Molgat-Seon Y., Ryerson C.J., Guenette J.A. Supplemental oxygen for the management of dyspnea in interstitial lung disease. Curr. Opin. Support. Palliat. Care. 2019;13(3):174-178. doi: 10.1097/SPC.0000000000000434.
  16. Toby Maher, Bryony Langford, Alex Diamantopoulos ey al. Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data Inoue European Respiratory Journal 2021 58: OA4238; DOI: 10.1183/13993003.congress-2021.OA4238

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*